Skip to main content
FDA Shortage Check

Is Heparin Sodium Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Heparin Sodium Injection: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: late Q4 2026”. Manufacturer’s estimate, B. Braun Medical Inc., Oct 19, 2026
DRUG
Heparin Sodium Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Nov 14, 2017
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 8 presentations: 1 unavailable · 3 limited · 4 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Heparin Sodium Injection. 8 presentations from 4 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

B. Braun Medical Inc.2 presentations · 2 limited

Contact (FDA's listing): 800-227-2862

  • 200 [USP'U]/100 mL

    Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)

    Estimated recovery: late Q4 2026; Manufacturing delays

    NDC 0264-9872-10Reverified

    Limited Availability

  • 200 [USP'U]/100 mL

    Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)

    Estimated recovery: late Q4 2026; Manufacturing delays

    NDC 0264-9872-00Reverified

    Limited Availability

Baxter Healthcare2 presentations · 1 limited · 1 available or not stated

Contact (FDA's listing): 888-229-0001

  • 200 [USP'U]/100 mL

    Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)

    Estimated recovery: December 2026

    NDC 0338-0431-03Revised

    Limited Availability

  • 200 [USP'U]/100 mL

    Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)

    NDC 0338-0433-04Reverified

    Available

Fresenius Kabi USA, LLC2 presentations · 1 unavailable · 1 available or not stated

Contact (FDA's listing): 888-386-1300

  • 200 [USP'U]/100 mL

    Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)

    Next release November 2026. Check wholesalers for inventory.

    NDC 63323-519-77Revised

    Unavailable

  • 200 [USP'U]/100 mL

    Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)

    Check wholesalers for inventory

    NDC 63323-519-10Reverified

    Available

Hospira, Inc., a Pfizer Company2 presentations · 2 available or not stated

Contact (FDA's listing): 844-646-4398

  • 1,000 Units/500 mL (2 Units/mL)

    Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20)

    NDC 0409-1005-20Reverified

    Available

  • 2,000 Units/1,000 mL (2 Units/mL)

    Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12)

    NDC 0409-2222-12Reverified

    Available

What the manufacturers told FDA

  • B. Braun Medical Inc. · ‘Estimated recovery: late Q4 2026; Manufacturing delays’ · updated Oct 2026
  • Baxter Healthcare · ‘Estimated recovery: December 2026’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Next release November 2026. Check wholesalers for inventory.’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Heparin Sodium Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Heparin Sodium Injection as currently in shortage: 8 presentations, 1 unavailable and 3 limited.
When will the Heparin Sodium Injection shortage end?
FDA gives no end date. 3 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Heparin Sodium Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.